DE LEO, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 589
EU - Europa 237
AS - Asia 93
SA - Sud America 17
AF - Africa 5
Totale 941
Nazione #
US - Stati Uniti d'America 561
IT - Italia 117
IN - India 40
SE - Svezia 40
SG - Singapore 29
CN - Cina 22
MX - Messico 21
FI - Finlandia 19
UA - Ucraina 16
DE - Germania 15
CO - Colombia 9
AR - Argentina 7
CA - Canada 6
ES - Italia 6
GB - Regno Unito 6
BG - Bulgaria 5
IE - Irlanda 5
TG - Togo 4
LU - Lussemburgo 3
CH - Svizzera 2
AL - Albania 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
GE - Georgia 1
IL - Israele 1
MA - Marocco 1
NL - Olanda 1
Totale 941
Città #
Fairfield 89
Chandler 66
Ann Arbor 56
Ashburn 37
Houston 27
Wilmington 27
Seattle 24
Rome 20
Cambridge 19
Princeton 19
Woodbridge 19
Plano 18
Singapore 16
Beijing 12
Boston 11
Milan 9
Des Moines 7
Federal 7
Millbury 7
Palermo 7
San Paolo di Civitate 7
Cagliari 6
Lawrence 6
Puebla City 6
San Diego 6
Andover 5
Jacksonville 5
Sofia 5
Bari 4
Dublin 4
Lomé 4
Mexico City 4
Palmira 4
Cartagena 3
Esch-sur-Alzette 3
Hefei 3
Indiana 3
Prato 3
Toronto 3
Ancaster 2
Bühl 2
Elche 2
Falls Church 2
Florence 2
Madrid 2
Marburg 2
Nanjing 2
Napoli 2
New York 2
Norwalk 2
Palakkad 2
Pasto 2
Pescara 2
Philadelphia 2
Phoenix 2
Saint Petersburg 2
Sant'Egidio alla Vibrata 2
Segovia 2
Tehuacán 2
Ticul 2
Arlington Heights 1
Asso 1
Bern 1
Boardman 1
Bremen 1
Dearborn 1
Delhi 1
Edinburgh 1
Fidenza 1
Forest City 1
Guangzhou 1
Helsinki 1
Ilvesheim 1
Jiaxing 1
Jinan 1
Kenitra 1
Kottayam 1
Kunming 1
La Spezia 1
London 1
Mannheim 1
Massa 1
Nettuno 1
Nürnberg 1
Osimo 1
Ottawa 1
Palagonia 1
Pune 1
Redwood City 1
Reston 1
Rimini 1
Salamanca 1
San Giorgio Del Sannio 1
San José 1
San Mateo 1
Santa Clara 1
Santiago 1
Southend 1
Tel Aviv 1
Terralba 1
Totale 663
Nome #
Il ciclo litico di EBV e la risposta autofagica in cellule di linfoma di Burkitt 178
Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication 101
Down-regulation of proteolytic complexes following EBV activation in BL cells 64
Inhibition of autophagy in EBV-positive Burkitt’s lymphoma cells enhances EBV lytic genes expression and replication 58
Epstein-Barr virus lytic cycle activation alters proteasome subunit expression in Burkitt's lymphoma cells 57
Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds 57
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets 50
Effects of Resveratrol on Epstein-Barr Virus (EBV) - infected B lymphocytes 49
PARP activation modulates apoptosis events in cellular and animal models of Alzheimer disease 47
Apoptotic events are modulated by poly(ADP-ribose)polymerase in cellular and animal models of Alzheimer disease 44
ANTIVIRAL EFFECTS OF RESVERATROL ON EPSTEIN BARR VIRUS LATENT AND LYTIC INFECTION 42
Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program 37
SILENZIAMENTO DELL’ ONCOGENE LMP1 DI EBV : EFFETTI SULLA INFEZIONE LATENTE E LITICA DEL VIRUS 33
Resveratrol Inhibition of Human Rhinovirus Replication 31
MODULATION OF MAPKS ACTIVITIES BY RESVERATROL IN EPSTEIN BARR VIRUS-POSITIVE BURKITT'S LYMPHOMA CELLS 30
EFFECTS OF RESVERATROL ON THE LATENT AND THE LYTIC PHASES OF EPSTEIN BARR VIRUS INFECTION 26
Inhibition of Epstein Barr Vurus Replication by resveratrol 25
RESVERATROL-INDUCED AUTOPHAGY CONTRIBUTES TO THE INHIBITION OF EPSTEIN BARR VIRUS REPLICATION IN BURKITT’S LYMPHOMA CELLS 19
Totale 948
Categoria #
all - tutte 2.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 5 4 7 17 14 19 20 15 7 14 6
2020/202136 2 7 1 5 0 0 0 9 3 5 4 0
2021/2022143 1 11 12 1 18 4 0 15 19 20 6 36
2022/2023192 33 35 14 15 17 30 7 14 12 11 4 0
2023/2024136 13 19 0 4 9 26 1 21 2 11 24 6
2024/202516 2 14 0 0 0 0 0 0 0 0 0 0
Totale 948